Endocrine Pathology — MCQs

A 72-year-old woman with a long history of type-2 diabetes mellitus presents with abdominal pain. Physical examination reveals neuromuscular weakness and hypertension. Laboratory studies show markedly reduced serum calcium and elevated parathyroid hormone (PTH). A surgical exploration of the patient's neck demonstrates 4 symmetrically enlarged parathyroid glands. Which of the following underlying disorders may be causing this patient's endocrinopathy?

Q189Medium

Histopathology of which of the following tumors shows a Zellballen pattern?

Q190Medium

All of the following familial syndromes are associated with the development of pheochromocytomas except?

Endocrine Pathology Indian Medical PG Practice Questions and MCQs

Question 181: Which of the following is NOT part of the rule of 10 for pheochromocytoma?

A. 10% are bilateral
B. 10% are malignant
C. 10% are extra-adrenal
D. 10% are symptomatic (Correct Answer)

Explanation: **Explanation:** Pheochromocytoma is a catecholamine-secreting tumor derived from chromaffin cells of the adrenal medulla [1]. It is classically known as the **"10% tumor"** because of its predictable distribution and behavior. **Why Option D is the Correct Answer:** The statement "10% are symptomatic" is incorrect because the vast majority of patients with pheochromocytoma (approximately **90% or more**) are **symptomatic** [1]. The classic triad consists of episodic headache, sweating (diaphoresis), and tachycardia, often accompanied by hypertension [1]. Only a small minority are discovered incidentally ("incidentalomas") without symptoms. **Analysis of the "Rule of 10":** * **10% are Extra-adrenal:** These occur in sites like the Organ of Zuckerkandl and are termed paragangliomas. * **10% are Bilateral:** Most commonly seen in familial syndromes like MEN 2A and 2B [2]. * **10% are Malignant:** Malignancy is defined strictly by the presence of metastases (e.g., to bone, liver, or lymph nodes), not by histology [3]. * **10% occur in Children:** Though primarily an adult tumor, a small percentage occurs in the pediatric population. * **10% are Familial:** Note that recent genomic studies suggest this number may actually be higher (up to 30-40%), but for exam purposes, the "Rule of 10" remains the standard teaching [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Zellballen Pattern:** The characteristic histological arrangement of tumor cells in nests surrounded by sustentacular cells. * **Diagnosis:** Best initial screening test is **24-hour urinary fractionated metanephrines** or plasma free metanephrines. * **Management:** Always give **Alpha-blockers first** (e.g., Phenoxybenzamine) before Beta-blockers to avoid a hypertensive crisis caused by unopposed alpha-adrenergic stimulation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1138-1139. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 419-420.

Question 182: Medullary carcinoma of the thyroid is associated with which of the following syndromes?

A. Multiple Endocrine Neoplasia type I (MEN I)
B. Multiple Endocrine Neoplasia type II (MEN II) (Correct Answer)
C. Fraumeni syndrome
D. Hashimoto's thyroiditis

Explanation: **Explanation:** **Medullary Thyroid Carcinoma (MTC)** is a neuroendocrine tumor derived from the **parafollicular C-cells** [2], which secrete calcitonin. While 75% of cases are sporadic, 25% are familial and strongly associated with **Multiple Endocrine Neoplasia type II (MEN II)** [1]. * **Why Option B is correct:** MEN II (both IIA and IIB) is caused by a germline mutation in the **RET proto-oncogene** [1]. MTC is the most consistent feature of MEN II, occurring in nearly 100% of affected individuals. [3] * **MEN IIA (Sipple Syndrome):** MTC + Pheochromocytoma + Parathyroid hyperplasia [1]. * **MEN IIB (Wagenmann-Froboese Syndrome):** MTC + Pheochromocytoma + Mucosal neuromas + Marfanoid habitus [1]. * **Why other options are incorrect:** * **MEN I (Wermer Syndrome):** Characterized by the "3 Ps"—Pituitary, Parathyroid, and Pancreatic islet cell tumors [3]. It is not associated with MTC. * **Li-Fraumeni Syndrome:** Caused by a **TP53** mutation; it predisposes to a wide range of tumors (SBLA syndrome: Sarcoma, Breast, Leukemia, Adrenal), but MTC is not a classic component. * **Hashimoto’s Thyroiditis:** An autoimmune condition that increases the risk of **Thyroid Lymphoma** [2] (specifically B-cell MALT lymphoma), not MTC. **High-Yield Clinical Pearls for NEET-PG:** * **Histology:** Look for nests of polygonal cells in an **amyloid stroma** (derived from pro-calcitonin), which stains with **Congo Red** (apple-green birefringence). * **Screening:** In MEN II families, prophylactic thyroidectomy is often performed based on RET mutation status. * **Tumor Marker:** Serum **Calcitonin** is used for diagnosis and monitoring recurrence [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1139-1140.

Question 183: Which of the following gene defects is associated with the development of medullary carcinoma of the thyroid?

A. RET proto-oncogene (Correct Answer)
B. APC gene
C. RB gene
D. BRCA1 gene

Explanation: **Explanation:** **Medullary Thyroid Carcinoma (MTC)** is a neuroendocrine neoplasm derived from the **parafollicular C-cells** of the thyroid, which secrete calcitonin [1, 2]. **Why RET is correct:** The **RET proto-oncogene** (located on chromosome 10q11.2) encodes a receptor tyrosine kinase. Gain-of-function mutations in RET are the hallmark of MTC [1]. * **Sporadic MTC (75%):** Somatic RET mutations are found in approximately 50% of cases. * **Familial MTC (25%):** Germline RET mutations are present in virtually 100% of cases associated with **MEN 2A and MEN 2B** syndromes [1]. Identifying this mutation is clinically vital as it dictates the timing of prophylactic thyroidectomy in carriers. **Why other options are incorrect:** * **APC gene:** Associated with **Familial Adenomatous Polyposis (FAP)**. While FAP increases the risk of the "cribriform-morular" variant of papillary thyroid carcinoma, it is not linked to MTC. * **RB gene:** A tumor suppressor gene associated with **Retinoblastoma** and osteosarcoma. * **BRCA1 gene:** Primarily associated with hereditary **breast and ovarian cancer** syndromes. **High-Yield Clinical Pearls for NEET-PG:** * **Amyloid Stroma:** Histologically, MTC is characterized by nests of polygonal cells with extracellular **amyloid deposits** (derived from pro-calcitonin), staining positive with **Congo Red** (apple-green birefringence) [3]. * **Biomarker:** Serum **Calcitonin** is used for diagnosis and monitoring recurrence [2]. Carcinoembryonic antigen (CEA) is also often elevated [2]. * **MEN 2A:** MTC + Pheochromocytoma + Parathyroid Hyperplasia [1]. * **MEN 2B:** MTC + Pheochromocytoma + Mucosal Neuromas/Marfanoid habitus [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431.

Question 184: Which of the following diseases is known as the "Great Masquerader"?

A. Chemodectoma
B. Argentaffinoma
C. Paraganglioma
D. Pheochromocytoma (Correct Answer)

Explanation: **Explanation:** **Pheochromocytoma** is famously known as the **"Great Masquerader"** because its clinical presentation is incredibly varied and often mimics other conditions [1]. It is a catecholamine-secreting tumor derived from the chromaffin cells of the adrenal medulla. The episodic release of epinephrine and norepinephrine leads to the classic triad of symptoms: **Palpitations, Perspiration (diaphoretic), and Pounding Headache [1].** Because these symptoms overlap with anxiety attacks, hyperthyroidism, essential hypertension, and even menopause, it is frequently misdiagnosed initially. **Analysis of Options:** * **Pheochromocytoma (Correct):** Its ability to mimic a wide range of cardiovascular and neurological disorders earns it the "Great Masquerader" title. * **Chemodectoma:** This is a type of paraganglioma specifically arising from the carotid body [4]. While it is a vascular tumor, it does not typically present with the systemic "masquerading" symptoms of catecholamine excess. * **Argentaffinoma:** This is an older term for **Carcinoid tumors**, which secrete serotonin. While they cause "Carcinoid Syndrome" (flushing, diarrhea), they are not historically referred to by this specific moniker. * **Paraganglioma:** These are extra-adrenal pheochromocytomas. While they share similar pathophysiology, the term "Great Masquerader" is classically associated with the adrenal-based Pheochromocytoma in medical literature. **High-Yield NEET-PG Pearls:** * **Rule of 10s:** 10% are bilateral, 10% are malignant, 10% are extra-adrenal, and 10% occur in children. * **Diagnosis:** Best initial screening test is **24-hour urinary fractionated metanephrines** or plasma free metanephrines. * **Genetics:** Associated with **MEN 2A and 2B**, von Hippel-Lindau (VHL) syndrome, and NF-1 [2]. * **Histology:** Characterized by **"Zellballen"** (nests of cells) surrounded by a vascular stroma [3]. * **Management:** Always give **Alpha-blockers (Phenoxybenzamine)** before Beta-blockers to avoid a hypertensive crisis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1138-1139. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 419-420. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 748-749.

Question 185: Medullary carcinoma of the thyroid is associated with an increase in which of the following?

A. Calcitonin (Correct Answer)
B. Thyroglobulin
C. T3
D. T4

Explanation: **Explanation:** **Medullary Thyroid Carcinoma (MTC)** is a neuroendocrine tumor derived from the **Parafollicular C-cells** of the thyroid gland [3, 4]. These cells are embryologically derived from the neural crest (ultimobranchial body) and their primary physiological function is the synthesis and secretion of **Calcitonin** [4]. 1. **Why Calcitonin is Correct:** Since MTC originates from C-cells, it serves as a functional tumor that secretes high levels of Calcitonin [1, 2]. In clinical practice, serum Calcitonin is used as a highly specific **tumor marker** for diagnosis, screening of high-risk relatives, and monitoring for postoperative recurrence. 2. **Why Incorrect Options are Wrong:** * **Thyroglobulin (B):** This is a protein produced by follicular cells. It is a marker for differentiated thyroid cancers (Papillary and Follicular), but not for MTC. * **T3 and T4 (C & D):** These are thyroid hormones produced by the follicular cells under the influence of TSH. MTC does not involve the follicular epithelium; therefore, patients are typically euthyroid, and these levels remain normal [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Amyloid Stroma:** Histologically, MTC is characterized by nests of polygonal cells with extracellular **amyloid deposits** (derived from pro-calcitonin), which stain with **Congo Red** (Apple-green birefringence) [1]. * **Genetics:** Approximately 25% of cases are familial, associated with **MEN 2A and 2B** syndromes due to germline mutations in the **RET proto-oncogene** [2, 3]. * **Other Markers:** MTC also secretes **Carcinoembryonic Antigen (CEA)**, which is useful for monitoring disease progression [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 430-431. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 424-426.

Question 186: Multiple submucosal neuromas are most likely associated with which of the following conditions?

A. Medullary carcinoma of the thyroid (Correct Answer)
B. Ovarian carcinoma
C. Testicular teratoma
D. Pancreatic beta cell carcinoma

Explanation: The presence of **multiple submucosal neuromas** (typically involving the tongue, lips, and eyelids) is a pathognomonic clinical sign of **Multiple Endocrine Neoplasia Type 2B (MEN 2B)**. **1. Why Medullary Carcinoma of the Thyroid is correct:** MEN 2B is an autosomal dominant syndrome caused by a mutation in the **RET proto-oncogene**. It is characterized by a triad of: * **Medullary Carcinoma of the Thyroid (MTC):** Occurs in 100% of cases, is aggressive, and often appears in early childhood. * **Pheochromocytoma:** Often bilateral [1]. * **Mucosal Neuromas and Marfanoid Habitus:** These are the distinguishing features that separate MEN 2B from MEN 2A [1]. Since MTC is a core component of this syndrome, it is the most likely association. **2. Why the other options are incorrect:** * **Ovarian Carcinoma:** Not associated with MEN syndromes or mucosal neuromas. * **Testicular Teratoma:** A germ cell tumor with no link to the RET mutation or neuroendocrine syndromes. * **Pancreatic Beta Cell Carcinoma (Insulinoma):** While pancreatic endocrine tumors are a hallmark of **MEN 1 (Wermer Syndrome)**, they are not associated with mucosal neuromas or MEN 2B. **High-Yield Clinical Pearls for NEET-PG:** * **MEN 2A (Sipple Syndrome):** MTC + Pheochromocytoma + Parathyroid Hyperplasia [1]. * **MEN 2B (Williams-Pollock Syndrome):** MTC + Pheochromocytoma + Mucosal Neuromas + Marfanoid Habitus. * **Key Difference:** MEN 2A has Hyperparathyroidism; MEN 2B has Neuromas/Marfanoid features [1]. * **Prophylactic Thyroidectomy:** Recommended in MEN 2 patients due to the high risk of early-onset MTC. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137.

Question 187: An autopsy is performed on an 8-year-old child with diabetes mellitus of recent onset who has died following an automobile accident. Which of the following autopsy findings would support the diagnosis of type 1 diabetes as contrasted to type 2 diabetes?

A. Amylin deposition in pancreatic islets
B. Armanni-Ebstein lesion
C. Insulitis (Correct Answer)
D. Kimmelstiel-Wilson nodules

Explanation: **Explanation:** **Correct Option: C. Insulitis** Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by the destruction of pancreatic beta cells [1]. The hallmark histopathological finding in the early stages of T1DM is **Insulitis**, which is a lymphocytic infiltration (primarily T-cells) of the islets of Langerhans [1]. This inflammatory process leads to progressive beta-cell depletion. In contrast, Type 2 Diabetes (T2DM) does not involve an autoimmune inflammatory infiltrate. **Analysis of Incorrect Options:** * **A. Amylin (Islet Amyloid) deposition:** This is a characteristic finding in **Type 2 Diabetes**. It results from the deposition of Islet Amyloid Polypeptide (IAPP), which is co-secreted with insulin. Over time, these deposits replace the islet cells. * **B. Armanni-Ebstein lesion:** This refers to the deposition of glycogen in the epithelial cells of the **distal convoluted tubules** and thick ascending limb of the loop of Henle. It is a non-specific finding seen in severe hyperglycemia/glycosuria and can occur in both T1DM and T2DM. * **D. Kimmelstiel-Wilson (KW) nodules:** Also known as nodular glomerulosclerosis, these are pathognomonic for **Diabetic Nephropathy**. While highly specific for diabetes, they occur in both types as a long-term microvascular complication and do not differentiate between the two. **High-Yield Clinical Pearls for NEET-PG:** * **T1DM Triad:** Genetic susceptibility (HLA-DR3/DR4), Environmental trigger, and Autoimmunity (Anti-GAD, Anti-IA2, and Anti-insulin antibodies) [1]. * **Most common cause of death in T1DM:** Renal failure (Diabetic Nephropathy). * **Most common cause of death in T2DM:** Cardiovascular disease (Myocardial Infarction). * **Insulitis** is most prominent in children with recent-onset T1DM; in long-standing cases, islets become atrophic and fibrotic. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1113-1114.

Question 188: A 72-year-old woman with a long history of type-2 diabetes mellitus presents with abdominal pain. Physical examination reveals neuromuscular weakness and hypertension. Laboratory studies show markedly reduced serum calcium and elevated parathyroid hormone (PTH). A surgical exploration of the patient's neck demonstrates 4 symmetrically enlarged parathyroid glands. Which of the following underlying disorders may be causing this patient's endocrinopathy?

A. Adrenal insufficiency
B. Chronic liver disease
C. Insulin deficiency
D. Renal insufficiency (Correct Answer)

Explanation: **Explanation:** The clinical presentation of **hypocalcemia**, **elevated PTH**, and **symmetrical enlargement of all four parathyroid glands** is the classic triad of **Secondary Hyperparathyroidism** [1]. **Why Renal Insufficiency is Correct:** Chronic Kidney Disease (CKD) is the most common cause of secondary hyperparathyroidism [1], [3]. The pathophysiology involves: 1. **Phosphate Retention:** Failing kidneys cannot excrete phosphate, leading to hyperphosphatemia [2]. High phosphate directly depresses serum calcium [1]. 2. **Vitamin D Deficiency:** Kidneys lose the ability to convert 25-hydroxyvitamin D to its active form, **1,25-dihydroxyvitamin D (Calcitriol)**, due to the loss of alpha-1 hydroxylase enzyme [1]. 3. **Hypocalcemia:** Reduced calcitriol leads to decreased intestinal calcium absorption [1]. The resulting low serum calcium chronically stimulates the parathyroid glands, leading to **compensatory chief cell hyperplasia** (symmetrical enlargement of all four glands) and high PTH levels to maintain calcium homeostasis [1], [3]. **Why Incorrect Options are Wrong:** * **Adrenal Insufficiency:** Typically presents with hypercalcemia (due to decreased renal excretion and increased bone resorption), not hypocalcemia. * **Chronic Liver Disease:** While it can lead to Vitamin D deficiency (impaired 25-hydroxylation), it is a much less common cause of secondary hyperparathyroidism compared to renal failure [1] and does not typically present with the severe biochemical profile seen here. * **Insulin Deficiency:** Type 1 Diabetes or advanced Type 2 Diabetes does not directly cause parathyroid hyperplasia. **NEET-PG High-Yield Pearls:** * **Primary Hyperparathyroidism:** Usually a single **adenoma** (85-90%); presents with **hypercalcemia** and high PTH ("Stones, bones, abdominal groans, and psychic moans") [3]. * **Secondary Hyperparathyroidism:** **Four-gland hyperplasia**; presents with **hypocalcemia** and high PTH [1]. * **Tertiary Hyperparathyroidism:** Occurs when PTH secretion becomes autonomous after long-standing secondary HPT (usually post-renal transplant); presents with **hypercalcemia** and very high PTH. * **Renal Osteodystrophy:** The collective bone changes (osteitis fibrosa cystica, osteomalacia) resulting from secondary hyperparathyroidism in CKD [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1105-1107. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1194-1195. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 667-668.

Question 189: Histopathology of which of the following tumors shows a Zellballen pattern?

A. Gastrointestinal stromal tumor (GIST)
B. Astrocytoma
C. Carotid body tumor (Correct Answer)
D. Retinoblastoma

Explanation: **Explanation:** The **Zellballen pattern** is the characteristic histopathological hallmark of **Paragangliomas**, including **Carotid body tumors** and Pheochromocytomas [1]. 1. **Why Carotid body tumor is correct:** Paragangliomas are neuroendocrine tumors derived from extra-adrenal chromaffin cells [3]. Microscopically, they consist of nests or clusters of round-to-oval chief cells (containing neurosecretory granules) surrounded by a delicate vascular stroma and peripheral spindle-shaped **sustentacular cells**. This nested architectural arrangement is termed "Zellballen" (German for "cell balls") [1]. 2. **Why other options are incorrect:** * **Gastrointestinal stromal tumor (GIST):** Characterized by bundles of spindle cells or epithelioid cells. It typically expresses **CD117 (c-KIT)**. * **Astrocytoma:** Features a fibrillary background of glial processes. High-grade versions (GBM) show pseudopalisading necrosis. * **Retinoblastoma:** Characterized by small round blue cells forming **Flexner-Wintersteiner rosettes** (lumen-containing) or Homer Wright rosettes [4]. **High-Yield Pearls for NEET-PG:** * **Stains:** Chief cells in Zellballen are positive for **Synaptophysin** and **Chromogranin**, while sustentacular cells are positive for **S-100**. * **Carotid Body Tumor:** Specifically located at the bifurcation of the common carotid artery; it is highly vascular and may exhibit the "Lyre sign" on angiography [3]. * **Rule of 10s:** Traditionally associated with Pheochromocytoma (10% bilateral, 10% malignant, 10% extra-adrenal), though genetic understanding is evolving [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1137-1138. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 748-749. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 211-212.

Question 190: All of the following familial syndromes are associated with the development of pheochromocytomas except?

A. Sturge-Weber syndrome
B. Von Recklinghausen disease
C. MEN Type II
D. Prader-Willi syndrome (Correct Answer)

Explanation: **Explanation:** Pheochromocytoma is a catecholamine-secreting tumor of the adrenal medulla [1]. Approximately **25–30%** of cases are associated with germline mutations in familial syndromes [1]. **1. Why Prader-Willi Syndrome (PWS) is the correct answer:** Prader-Willi syndrome is a genetic disorder caused by the loss of function of specific genes on **chromosome 15** (paternal imprinting) [2]. It is clinically characterized by hyperphagia, obesity, intellectual disability, and hypogonadism [2]. It has **no known association** with the development of pheochromocytomas or any other neuroendocrine tumors. **2. Analysis of Incorrect Options (Associated Syndromes):** * **MEN Type II (A and B):** Strongly associated with pheochromocytoma (approx. 50% of patients) due to **RET proto-oncogene** mutations [1]. * **Von Recklinghausen Disease (Neurofibromatosis Type 1):** Caused by mutations in the **NF1 gene**. About 1–3% of NF1 patients develop pheochromocytomas [1]. * **Sturge-Weber Syndrome:** While rare, this phakomatosis (encephalotrigeminal angiomatosis) is classically listed in pathology textbooks as a minor association with pheochromocytoma, alongside other neurocutaneous syndromes. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of 10s"** (though now debated) is a classic exam favorite: 10% bilateral, 10% malignant, 10% extra-adrenal (paragangliomas), and 10% in children [1]. * **Von Hippel-Lindau (VHL) Syndrome:** Another major association (VHL gene on chromosome 3p) [1]. * **SDH Mutations:** Mutations in Succinate Dehydrogenase (SDHB, SDHD) are high-yield causes of familial paragangliomas and pheochromocytomas [1]. * **Diagnosis:** Best initial screening test is **Urinary/Plasma Metanephrines** (higher sensitivity than catecholamines). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1137-1139. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 181-182.

Practice by Chapter

Pituitary Gland Disorders

Practice Questions

Thyroid Gland Diseases

Practice Questions

Parathyroid Gland Pathology

Practice Questions

Adrenal Cortical Disorders

Practice Questions

Adrenal Medullary Disorders

Practice Questions

Pancreatic Endocrine Disorders

Practice Questions

Multiple Endocrine Neoplasia Syndromes

Practice Questions

Diffuse Neuroendocrine System

Practice Questions

Pineal Gland Pathology

Practice Questions

Laboratory Diagnosis of Endocrine Diseases

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free